6 terminated. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Terminated 6 |
Follow brodalumab: new trials by email Literature Review of brodalumab trials Research Report on brodalumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis Brodalumab, Ustekinumab, Placebo - Psoriasis | Phase 3 | Terminated | LEO Pharma | 12 | 2022-12-07 | 2025-03-14 |
| Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis 210 mg brodalumab, 140 mg brodalumab, Placebo - Psoriatic Arthritis | Phase 3 | Terminated | Bausch Health Americas, Inc. | 478 | 2014-03-01 | 2017-05-19 |
| Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects 210 mg brodalumab, 140 mg brodalumab, ustekinumab - Plaque Psoriasis | Phase 3 | Terminated | Bausch Health Americas, Inc. | 1881 | 2012-09-01 | 2020-01-03 |
| P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis 210 mg brodalumab, 140 mg brodalumab, ustekinumab - Moderate to Severe Plaque Psoriasis | Phase 3 | Terminated | Bausch Health Americas, Inc. | 1831 | 2012-08-01 | 2020-01-06 |
| Study to Evaluate Broadlumab vs Placebo and Ustekinumab 210mg Brodalumab, 140mg Brodalumab, Ustekinumab - Psoriasis | Phase 3 | Terminated | MedDerm Associates | 15 | 2012-08-01 | 2016-06-01 |
| Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects 210 mg brodalumab, 140 mg brodalumab, placebo - Psoriasis | Phase 3 | Terminated | Bausch Health Americas, Inc. | 661 | 2012-08-01 | 2020-01-03 |
Psoriasis (5) · Arthritis, Psoriatic (1)
Bausch Health Americas, Inc. (4) · LEO Pharma (1) · MedDerm Associates (1)
France (5) · Poland (5) · United States (5) · Canada (4) · Hungary (4) · Belgium (3) · Greece (3) · Italy (3) · Spain (3) · Australia (2) · Czechia (2) · Germany (2) · Russia (2) · Switzerland (2) · Austria (1)
PMID 32207067, PMID 26422722, PMID 30328108, PMID 30471012, PMID 34606048, PMID 39264399
2019 (1)